TY  - GEN
AU  - Kimer,Nina
AU  - Gudmann,Natasja Stæhr
AU  - Pedersen,Julie Steen
AU  - Møller,Søren
AU  - Nielsen,Mette Juul
AU  - Leeming,Diana Julie
AU  - Karsdal,Morten Asser
AU  - Møller,Holger Jon
AU  - Bendtsen,Flemming
AU  - Grønbæk,Henning
TI  - No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial
SN  - 1932-6203
PY  - 2019///0221
KW  - Adult
KW  - Aged
KW  - Antigens, CD
KW  - blood
KW  - Antigens, Differentiation, Myelomonocytic
KW  - Biomarkers
KW  - Collagen Type III
KW  - Collagen Type IV
KW  - Double-Blind Method
KW  - Female
KW  - Gastrointestinal Agents
KW  - therapeutic use
KW  - Humans
KW  - Lectins, C-Type
KW  - Liver Cirrhosis
KW  - Male
KW  - Mannose Receptor
KW  - Mannose-Binding Lectins
KW  - Middle Aged
KW  - Receptors, Cell Surface
KW  - Rifaximin
KW  - Severity of Illness Index
KW  - Treatment Outcome
KW  - CD163 Antigen
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1371/journal.pone.0203200
ER  -